Fidson Healthcare Plc has been selected to manufacture a generic version of Roche's influenza drug, baloxavir marboxil, for supply to 129 countries. This development is expected to strengthen health security by expanding access to the treatment.
Related Articles
Don't miss out on breaking stories and in-depth articles.